Always Visit www.NaijaCover.Com

Posted By Admin On April 2nd, 2025

The Director General of National Agency for Food Drug Administration and Control (NAFDAC), Prof. Mojisola Adeyeye has announced the reopening of Onitsha Head Bridge drug market, popularly known as ‘Ogbo Ogwu’.

NAFDAC also announced that shop owners must meet strict administrative conditions before the reopening of their shops to prevent a recurrence of the issues that led to the closure.

This was made known on Wednesday in a statement signed by Adeyeye, NAFDAC DG.

According to the DG, shop owners are required to complete documentation and clearance procedures before their shops could be unsealed.

Adeyeye also disclosed that a dedicated NAFDAC desk has been established to facilitate the process efficiently, ensuring compliance with regulatory standards.

She stated that only shops that meet the conditions will be allowed to resume operations.

Parts of the statement read: “The National Agency for Food and Drug Administration and Control (NAFDAC) has reopened the Bridgehead Drug Market in Onitsha following a month-long closure for sanitisation and regulatory enforcement.

“To prevent a recurrence of the issues that led to the closure, NAFDAC implemented strict administrative conditions for reopening.

“Shop owners were required to complete documentation and clearance procedures before their shops could be unsealed.

“A dedicated NAFDAC desk was established to facilitate this process efficiently, ensuring compliance with regulatory standards.

“The Director-General of NAFDAC, Prof. Mojisola Adeyeye, emphasises that the market has now been reopened, with all shop owners directed through their union to obtain and sign an undertaking, along with a penalty for past violations of distribution regulations.

“Only shops that meet these conditions will be allowed to resume operations.”

DAILY POST reported that NAFDAC closed the market as it clamped down on fake and expired drugs dealers.

Source: https://dailypost.ng/2025/04/02/nafdac-reopens-onitsha-drug-market-issues-fresh-conditions-to-traders/